Chemotherapy and donor leukocyte infusions for relapsed juvenile myelomonocytic leukemia (JMML) [3]

Bone Marrow Transplantation

Volumn 33, Issue 10, 2004, Pages 1069-

  Neudorf, A ^a   Nourani, A ^a   Kempert, P ^a   Shen, V ^a   Sender, L ^a   Kirov, I ^a  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN F; HLA A ANTIGEN; METHYLPREDNISOLONE; MITOXANTRONE; THIOTEPA; THYMOCYTE ANTIBODY;

BLOOD ANALYSIS; CANCER RECURRENCE; CASE REPORT; COLONY FORMATION; DISEASE CLASSIFICATION; DRUG WITHDRAWAL; GRAFT VERSUS HOST REACTION; HEPATOSPLENOMEGALY; HOSPITAL DISCHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; JUVENILE MYELOMONOCYTIC LEUKEMIA; LABORATORY TEST; LETTER; LEUKOCYTE TRANSFUSION; LYMPHOCYTE DEPLETION; MONOCYTOSIS; PRIORITY JOURNAL; SKIN MANIFESTATION; SPLENECTOMY; T LYMPHOCYTE; WHOLE BODY RADIATION;

BONE MARROW TRANSPLANTATION; GRAFT VS LEUKEMIA EFFECT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; LYMPHOCYTE TRANSFUSION; MALE; RECURRENCE; REMISSION INDUCTION; TIME FACTORS; TRANSPLANTATION CONDITIONING;

EID: 2942619109     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704478     Document Type: Letter

References (4)

1. Matthes-Martin S, Mann G, Peters C et al. Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single center experience and review of the literature. Bone Marrow Transplantation 2000; 26: 377-382.
2. Worth A, Rao K, Webb D et al. Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion. Blood 2003; 101: 1713-1714.
3. Orchard P, Miller J, McGlennen R et al. Graft-versus-leukemia is sufficient to induce remission in juvenile myelomonocytic leukemia. Bone Marrow Transplantation 1998; 22: 201-203.
4. Wells RJ, Adams MT, Alonzo TA et al. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951. J Clin Onc 2003; 21: 2940-2947.